NOV 002

Known as: NOV-002, NOV002, Oxidized Glutathione NOV-002 
A stabilized formulation of disodium glutathione disulfide (GSSG; oxidized glutathione) and cisplatin (1000:1) with potential chemoprotective and… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2005-2015
012320052015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Metastasis is the major cause of death in cancer. Most therapies currently in the clinic aim to eradicate primary tumor, but do… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2012
2012
The oxidized glutathione mimetic NOV-002 is a unique anti-tumor agent that not only has the ability to inhibit tumor cell… (More)
Is this relevant?
2011
2011
NOV-002 (a formulation of disodium glutathione disulfide) modulates signaling pathways involved in tumor cell proliferation and… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2010
2010
NOV-002 is a glutathione disulfide (GSSG) mimetic that is the subject of clinical investigation in oncology indications. GSSG is… (More)
  • figure 1
  • figure 3
  • figure 2
  • table 1
  • table 2
Is this relevant?
2010
2010
NOV-002 is a glutathione disulfide (GSSG) mimetic with chemoprotective activity. Previous and ongoing clinical studies… (More)
Is this relevant?
2009
2009
NOV-002 is a novel therapeutic agent in development for oncology indications used in combination with chemotherapy. Clinical… (More)
Is this relevant?
2008
2008
NOV-002 is a novel glutathione disulfide mimetic that when administered in combination with standard chemotherapeutic regimens… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2008
2008
NOV-002 is a novel glutathione disulfide mimetic that when administered in combination with standard chemotherapeutic regimens… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
Review
2008
Review
2008
BACKGROUND Oxidative signaling to modulate redox-sensitive cell functions is a heretofore unexploited approach to developing new… (More)
Is this relevant?
2006
2006
17021 Background: NOV-002 is a proprietary formulation of oxidized glutathione that modulates production of cytokines and… (More)
Is this relevant?